In response to the rise of generic GLP-1 weight-loss drugs in India, the drug regulator is stepping up audits and enforcement actions against unauthorized sales and improper prescriptions, ensuring patient safety as the market expands amid an obesity crisis.
You will be redirected in 10 seconds.